<DOC>
	<DOC>NCT03094845</DOC>
	<brief_summary>hdmASIT+TM product is based on highly purified allergen fragments from house dust mites. The purpose of this study is to assess the safety and clinical tolerability of subcutaneous immunotherapy with hdmASIT+TM in patients with house dust mite-induced allergic rhinoconjunctivitis compared to placebo.</brief_summary>
	<brief_title>Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients</brief_title>
	<detailed_description />
	<criteria>A medical history of moderate to severe allergic rhinoconjunctivitis for house dust mite for at least 12 months (definition of allergy severity according to ARIA (Bousquet et al., 2001)) A positive skin prick test to house dust mite Dermatophagoides pteronyssinus Specific IgE against house dust mite Dermatophagoides pteronyssinus ≥ 0.7 kU/L Positive response to Conjunctival Provocation Test (CPT) Being treated with antiallergic medication for at least 12 months prior to enrollment For asthmatic patients: confirmed diagnosis of controlled asthma according to Global Initiative for Asthma (GINA) guidelines (steps 13, GINA 2014), FEV1 ≥ 80% of the patient's reference value Previous immunotherapy with house dust mite allergens within the last 5 years Ongoing immunotherapy with house dust mite allergens or any other allergens History of severe systemic reactions and/or anaphylaxis, including to food (e.g. peanut, marine animals) or to Hymenoptera venom (e.g. bee, wasp stings) or to medication (e.g. penicillin), etc. Partly controlled or uncontrolled asthma according to GINA guidelines (GINA 2014) Chronic asthma or emphysema, particularly with a forced expiratory volume in 1 second (FEV1) &lt; 80% of the patient's reference value (ECSC) History of a respiratory tract infection and/or exacerbation of asthma within 4 weeks before the screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>